HOUSTON, Sept. 4, 2024 /PRNewswire/ -- Constantiam Biosciences, a startup focused on powering genomic medicine, is pleased to announce that it has been awarded a $2.05 million Phase II Small Business ...
HOUSTON, TX, UNITED STATES, October 29, 2024 /EINPresswire.com/ -- Constantiam Biosciences, a biotechnology startup specializing in high-throughput experimentation ...
With MAVEvidence, we're advancing genetic variant interpretation, empowering clinicians to accurately assess Alzheimer's and dementia risks for early personalized detection and precision care.” - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results